Langerian mindfulness for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Southern California, Los Angeles, CA
Stroke+3 More
Langerian mindfulness - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Effectiveness of Mindfulness After a Stroke

See full description

Eligible Conditions

  • Stroke
  • Caregivers Burnout

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

This trial is evaluating whether Langerian mindfulness will improve 3 primary outcomes and 4 secondary outcomes in patients with Stroke. Measurement will happen over the course of 2 months.

2 months
Change from baseline on NIH Toolbox Perceived Stress Survey (PSS)
Change from baseline on Single-item Sleep Quality Scale (SQS)
Change from baseline on Stroke-specific Quality of Life (SS-QOL)
Change from baseline on World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Change from baseline on Zarit Burden Interview
Change from baseline on the Hospital Anxiety and Depression Scale (HADS)
change in the modified Ashworth Scale (elbow)

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Caregivers - Waitlist control
1 of 4
Stroke survivors - Waitlist control
1 of 4
Stroke survivors - Mindfulness intervention
1 of 4
Caregivers - Mindfulness intervention
1 of 4
Active Control
Experimental Treatment

This trial requires 44 total participants across 4 different treatment groups

This trial involves 4 different treatments. Langerian Mindfulness is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Stroke survivors - Mindfulness intervention
Behavioral
Participants who have had a stroke who are receiving the mindfulness intervention immediately after enrollment (no wait period).
Caregivers - Mindfulness intervention
Behavioral
Participants caring for someone who have had a stroke and receiving the mindfulness intervention immediately after enrollment (no wait period).
Caregivers - Waitlist controlParticipants caring for someone who have had a stroke assigned to the waitlist.
Stroke survivors - Waitlist controlParticipants who have had a stroke who are assigned to the waitlist.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 2 months for reporting.

Who is running the study

Principal Investigator
C. W.
Prof. Carolee Winstein, Professor
University of Southern California

Closest Location

University of Southern California - Los Angeles, CA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Stroke survivor or caregiver of someone who have had a stroke
Fluent in English
Have access to Internet using a computer, a tablet and/or a smart phone.

Patient Q&A Section

What are the signs of stroke?

"Stroke may present with confusion, vomiting, a change in temperament, a change in language, a change to one-sided arm paralysis and hemiplegia. If left untreated, stroke can lead to loss of control and right neglect." - Anonymous Online Contributor

Unverified Answer

Can stroke be cured?

"There are multiple facets of symptom improvement including increased willingness to seek help, and increased number of appointments with the clinic physician, but stroke should not be thought of as a mere symptom, but rather as a pathology that can be managed as such." - Anonymous Online Contributor

Unverified Answer

What is stroke?

"Stroke is a disease that results in a sudden and usually permanent loss of function and brain damage to the area of the brain involved. About 17% of the USA’s population has had a stroke or stroke-like condition and 6 of 10 people who are alive will have a stroke in their lifetime. Strokes occur in all ages and gender groups. The brain damage caused by the disease is usually irreversible; however, many survivors go on to be productive, fulfilling members of society." - Anonymous Online Contributor

Unverified Answer

What are common treatments for stroke?

"As the global burden of disease and associated healthcare costs diminish, the proportion of strokes that heal and remain stroke free and the proportion of strokes for which there is no treatment are unlikely to increase. The proportion of stroke patients needing treatment and improving quality of life will likely remain constant. Nevertheless, it is critical to provide effective, evidence-based treatments to people with stroke." - Anonymous Online Contributor

Unverified Answer

What causes stroke?

"Different types of stroke are associated with certain risk factors. A number of other factors can be affected by stroke. Aspects that affect outcomes can include the speed of onset, severity, and long-term effects of the stroke. Preventing stroke in the future requires a detailed breakdown of the various factors that contribute to and are affected by stroke." - Anonymous Online Contributor

Unverified Answer

How many people get stroke a year in the United States?

"It seems surprising that we did not find an estimate that stroke is the leading cause of death among Caucasians. The incidence of stroke may be higher, especially among African Americans than estimates from the epidemiology are expected to show. Stroke prevention programmes in the US are warranted." - Anonymous Online Contributor

Unverified Answer

Have there been any new discoveries for treating stroke?

"This chapter will discuss some of the major findings in stroke research for the year 2010 where we may discover a treatment that will change the treatment paradigm for the treatment of stroke. The discoveries should lead into a new era of research where we may discover new information on both the mechanisms of stroke and better treatments for the neurological sequelae and complications of stroke." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in langerian mindfulness for therapeutic use?

"These techniques have not yet been established in a formal manner and therefore do not follow the basic principles of mindfulness itself. This review does provide a small introductory guideline for the treatment by introducing the concept of the Langerian-mindfulness, and some of the possible therapeutic uses thereof, and thus contributes to new perspectives in the field of mindfulness research." - Anonymous Online Contributor

Unverified Answer

What is langerian mindfulness?

"It has been established that the Langerian approach has some relevance to the study of neurodegenerative disease. Recently it is also being explored as an alternative to psychotherapy. It seems that it is a new approach that is likely to have implications for the future of neuropsychiatry. As a term is used by the neuroscience community, it is better to take langerian mindfulness on its own merits unless one has something more to gain and perhaps an understanding of why it is different from other more established methods. However one may benefit from investigating it in light of existing evidence of this method's utility which is currently growing more and more." - Anonymous Online Contributor

Unverified Answer

What is the primary cause of stroke?

"Primary stroke prevention encompasses approaches not only to reduce atherosclerotic stroke but also to prevent cerebrovascular events (e.g., embolic stroke). As primary prevention requires the identification and control of risk factors for cardiovascular events, many of the risk factors that contribute to the development of stroke are preventable. If treatment options to modify and reduce the risk of stroke are available and effective, there are no compelling arguments that stroke prevention only be targeted at secondary prevention." - Anonymous Online Contributor

Unverified Answer

How does langerian mindfulness work?

"Results from a recent clinical trial show that a short training course in LMM reduces negative affect. However, no changes in mindfulness were found after the intervention in either the self-reported or physiological measures of state mindfulness, but that a lower level of state mindfulness was associated with a greater negative affect." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Stroke by sharing your contact details with the study coordinator.